RE: Administration24 Jun 2025 12:13
Received this from Administration on 17th June 2025
I think the Directors have lied to us at the last fund raise.
Is there someone out there willing to make a case for us ?
refer to your email, please accept my apologies for the delayed response.
I can confirm that Nicola Baker was appointed as Administrator of Oxford Cannabinoid Technologies Plc (“the Company”) on 2 May 2025.
It is my understanding that the Company de-listed its shares from the London Stock Exchange on 6 June 2024.
I can confirm that Oxford Cannabinoid Technologies Ltd (CRN: 10664635) is a wholly owned subsidiary of the Company in Administration (CRN: 13179529), and I can also confirm that there are common directors.
It is the Administrators intention to sell the Company’s assets as a whole, in order to maximise realisations.
With regards to the shareholding and investments in the Company, unfortunately shareholders are at the bottom of the priority hierarchy in insolvency, and are only entitled to the remaining assets of the Company after all creditors have been paid in full.
Due to the insolvency of the Company, it is highly unlikely the shareholders will receive a return on their investment, as the Company’s assets are insufficient to cover all debts and expenses of the process.
Unfortunately shareholders bear the greatest risk, and potential reward, in a company’s performance. For example if the Company does well, shareholders benefit through dividends and capital appreciation, conversely, if a company becomes insolvent, shareholders bear the primary loss.
If you have any concerns with regards to the conduct of the Company or any of its directors I should be obliged if you would forward these to me, as the Administrator has a duty to investigation these matters and submit a report to the Secretary of State.
Yours sincerely
For and on behalf of
Oxford Cannabinoid Technologies Plc
Dominic Wolski for
Nicola Baker
Administrator